PetMed Express, Inc. (NASDAQ:PETS) CFO Bruce S. Rosenbloom sold 6,833 shares of the stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $50.18, for a total value of $342,879.94. Following the transaction, the chief financial officer now directly owns 18,534 shares of the company’s stock, valued at $930,036.12. The sale was disclosed in a document filed with the SEC, which is accessible through this link.
Shares of PetMed Express, Inc. (NASDAQ PETS) traded up 2.53% during mid-day trading on Friday, hitting $47.76. The company had a trading volume of 538,379 shares. The company has a market capitalization of $969.15 million, a P/E ratio of 36.74 and a beta of 0.99. The firm’s 50-day moving average price is $43.59 and its 200 day moving average price is $30.19. PetMed Express, Inc. has a one year low of $18.90 and a one year high of $50.90.
PetMed Express (NASDAQ:PETS) last posted its quarterly earnings results on Monday, July 24th. The company reported $0.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.07. PetMed Express had a net margin of 10.34% and a return on equity of 28.67%. The company had revenue of $79.66 million for the quarter, compared to analyst estimates of $77.32 million. During the same quarter in the previous year, the firm posted $0.32 earnings per share. The company’s quarterly revenue was up 9.9% compared to the same quarter last year. Analysts predict that PetMed Express, Inc. will post $1.44 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, August 18th. Investors of record on Monday, August 7th will be issued a dividend of $0.20 per share. This represents a $0.80 dividend on an annualized basis and a yield of 1.68%. The ex-dividend date of this dividend is Thursday, August 3rd. PetMed Express’s dividend payout ratio (DPR) is presently 61.54%.
TRADEMARK VIOLATION WARNING: “Bruce S. Rosenbloom Sells 6,833 Shares of PetMed Express, Inc. (NASDAQ:PETS) Stock” was published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this piece of content on another publication, it was copied illegally and republished in violation of United States & international trademark and copyright law. The original version of this piece of content can be read at https://stocknewstimes.com/2017/08/12/petmed-express-inc-nasdaqpets-cfo-bruce-s-rosenbloom-sells-6833-shares-updated.html.
A number of hedge funds have recently bought and sold shares of the company. Dimensional Fund Advisors LP raised its stake in PetMed Express by 8.3% in the second quarter. Dimensional Fund Advisors LP now owns 860,601 shares of the company’s stock worth $34,940,000 after buying an additional 65,932 shares during the period. Hancock Holding Co. raised its stake in PetMed Express by 4.9% in the second quarter. Hancock Holding Co. now owns 55,905 shares of the company’s stock worth $2,269,000 after buying an additional 2,602 shares during the period. EAM Investors LLC purchased a new stake in PetMed Express during the second quarter worth $3,960,000. Parametric Portfolio Associates LLC boosted its position in PetMed Express by 40.4% in the second quarter. Parametric Portfolio Associates LLC now owns 87,135 shares of the company’s stock worth $3,538,000 after buying an additional 25,053 shares in the last quarter. Finally, Advisor Group Inc. boosted its position in PetMed Express by 0.7% in the second quarter. Advisor Group Inc. now owns 24,844 shares of the company’s stock worth $1,009,000 after buying an additional 179 shares in the last quarter. 78.36% of the stock is currently owned by institutional investors and hedge funds.
PETS has been the subject of several research reports. Craig Hallum lowered PetMed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, July 11th. Noble Financial reissued a “hold” rating on shares of PetMed Express in a research note on Wednesday, July 26th. Zacks Investment Research raised PetMed Express from a “hold” rating to a “strong-buy” rating and set a $38.00 price objective for the company in a research note on Wednesday, May 10th. Finally, Northcoast Research raised PetMed Express from a “neutral” rating to a “buy” rating and set a $54.00 target price for the company in a research report on Monday, July 24th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of $35.00.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.